NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...
Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...
In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results